Helen Lau

934 total citations
23 papers, 610 citations indexed

About

Helen Lau is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Family Practice. According to data from OpenAlex, Helen Lau has authored 23 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Family Practice. Recurrent topics in Helen Lau's work include Blood Pressure and Hypertension Studies (7 papers), Medication Adherence and Compliance (4 papers) and Pharmaceutical Practices and Patient Outcomes (4 papers). Helen Lau is often cited by papers focused on Blood Pressure and Hypertension Studies (7 papers), Medication Adherence and Compliance (4 papers) and Pharmaceutical Practices and Patient Outcomes (4 papers). Helen Lau collaborates with scholars based in United States, Switzerland and Italy. Helen Lau's co-authors include Albert Marchetti, Leann Olansky, Patrick J. Boyle, Raf Magar, John P. Martin, Allen B. King, Gregory A. Nichols, Suma Vupputuri, Feride Frech‐Tamas and Confidence M. Gbarayor and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Internal Medicine and Diabetes Care.

In The Last Decade

Helen Lau

22 papers receiving 577 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Helen Lau United States	13	179	174	129	80	59	23	610
Julien Bezin France	18	251 1.4×	157 0.9×	182 1.4×	84 1.1×	155 2.6×	67	1.2k
Jaejin An United States	17	245 1.4×	74 0.4×	261 2.0×	64 0.8×	67 1.1×	72	820
Jochen Schuler Austria	9	136 0.8×	130 0.7×	271 2.1×	62 0.8×	56 0.9×	10	691
Stefan Viktor Vormfelde Germany	17	167 0.9×	261 1.5×	111 0.9×	15 0.2×	108 1.8×	37	907
Pernelle Noïze France	16	64 0.4×	58 0.3×	121 0.9×	63 0.8×	66 1.1×	62	840
Silvana Romio Netherlands	14	114 0.6×	90 0.5×	192 1.5×	26 0.3×	139 2.4×	27	912
Jenifer Wogen United States	12	291 1.6×	93 0.5×	137 1.1×	115 1.4×	71 1.2×	28	714
So Mi Jemma Cho South Korea	15	146 0.8×	48 0.3×	404 3.1×	31 0.4×	95 1.6×	48	845
Shinzo Hiroi Japan	16	434 2.4×	203 1.2×	97 0.8×	44 0.6×	248 4.2×	47	789
Kari Harno Finland	18	476 2.7×	74 0.4×	155 1.2×	24 0.3×	139 2.4×	38	948

Countries citing papers authored by Helen Lau

Since Specialization

Citations

This map shows the geographic impact of Helen Lau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Lau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Lau more than expected).

Fields of papers citing papers by Helen Lau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Lau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Lau. The network helps show where Helen Lau may publish in the future.

Co-authorship network of co-authors of Helen Lau

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Lau. A scholar is included among the top collaborators of Helen Lau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Lau. Helen Lau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Martini, Nataly, et al.. (2022). Assessing antibiotic prescribing in nurse practitioners: Applied cognitive task analysis. International Journal of Nursing Studies Advances. 4. 100101–100101.

Schottinger, Joanne E., et al.. (2016). Using Literature Review and Structured Hybrid Electronic/Manual Mortality Review to Identify System-Level Improvement Opportunities to Reduce Colorectal Cancer Mortality. The Joint Commission Journal on Quality and Patient Safety. 42(7). 303–AP2. 3 indexed citations

Gould, Michael K., et al.. (2015). Incidence of Venous Thromboembolism Following Major Surgery: Opportunities for Care Improvement. Journal of patient-centered research and reviews. 2(2). 96–97. 1 indexed citations

Lau, Helen, et al.. (2014). E-Autopsy: Using Structured Hybrid Manual/Electronic Mortality Reviews to Identify Quality Improvement Opportunities. The Joint Commission Journal on Quality and Patient Safety. 40(10). 444–AP4. 3 indexed citations

Iwata, Hiroji, José Baselga, Mario Campone, et al.. (2013). Ph III randomized studies of the oral pan-PI3K inhibitor buparlisib (BKM120) with fulvestrant in postmenopausal women with HR+/HER2– locally advanced or metastatic breast cancer (BC) after aromatase inhibitor (AI; BELLE-2) or AI and mTOR inhibitor (BELLE-3) treatment.. Journal of Clinical Oncology. 31(15_suppl). TPS650–TPS650. 8 indexed citations

Tuso, Philip, Gail Lindsay, Heather Watson, et al.. (2013). The Readmission Reduction Program of Kaiser Permanente Southern California—Knowledge Transfer and Performance Improvement. The Permanente Journal. 17(3). 58–63. 37 indexed citations

Porter, John B., Donald K. Bowden, Marina Economou, et al.. (2012). Health-Related Quality of Life, Treatment Satisfaction, Adherence and Persistence inβ-Thalassemia and Myelodysplastic Syndrome Patients with Iron Overload Receiving Deferasirox: Results from the EPIC Clinical Trial. Anemia. 2012. 1–10. 57 indexed citations

Lau, Helen, et al.. (2011). Saving Lives by Studying Deaths: Using Standardized Mortality Reviews to Improve Inpatient Safety. The Joint Commission Journal on Quality and Patient Safety. 37(9). 400–AP2. 29 indexed citations

Brixner, Diana, Carrie McAdam‐Marx, Xiangyang Ye, Helen Lau, & Mark A. Munger. (2010). Assessment of time to follow-up visits in newly-treated hypertensive patients using an electronic medical record database. Current Medical Research and Opinion. 26(8). 1881–1891. 4 indexed citations

10.

Delea, Thomas E., Oleg Sofrygin, James L. Palmer, et al.. (2009). Cost-Effectiveness of Aliskiren in Type 2 Diabetes, Hypertension, and Albuminuria. Journal of the American Society of Nephrology. 20(10). 2205–2213. 18 indexed citations

11.

Suh, Dong‐Churl, et al.. (2009). Association between incidence of acute exacerbation and medication therapy in patients with COPD. Current Medical Research and Opinion. 26(2). 297–306. 10 indexed citations

12.

Shaya, Fadia T., et al.. (2009). Predictors of Compliance with Antihypertensive Therapy in a High-Risk Medicaid Population. Journal of the National Medical Association. 101(1). 34–39. 67 indexed citations

13.

Suh, Dong‐Churl, et al.. (2008). Sex Differences in Ambulatory Visits for Chronic Obstructive Pulmonary Disease, Based on the National Ambulatory Medical Care Survey and the National Hospital Ambulatory Medical Care Survey from 1995 to 2004. Respiratory Care. 53(11). 1461–1469. 13 indexed citations

14.

Shaya, Fadia T., et al.. (2008). Predictors of fixed-dose combination antihypertensive drug therapy in a Medicaid population. Journal of the American Society of Hypertension. 2(6). 469–475. 1 indexed citations

15.

Hess, Gregory P., et al.. (2008). Medication Utilization Patterns and Hypertension-Related Expenditures among Patients Who Were Switched from Fixed-Dose To Free-Combination Antihypertensive Therapy.. PubMed. 33(11). 652–66. 34 indexed citations

16.

Peters, Anne L., David M. Kendall, John B. Buse, et al.. (2004). Impact of adjunctive thiazolidinedione therapy on blood lipid levels and glycemic control in patients with type 2 diabetes. Current Medical Research and Opinion. 20(2). 215–223. 39 indexed citations

17.

Olansky, Leann, Albert Marchetti, & Helen Lau. (2003). Multicenter retrospective assessment of thiazolidinedione monotherapy and combination therapy in patients with type 2 diabetes: Comparative subgroup analyses of glycemic control and blood lipid levels. Clinical Therapeutics. 25. B64–B80. 33 indexed citations

18.

Boyle, Patrick J., Allen B. King, Leann Olansky, et al.. (2002). Effects of Pioglitazone and rosiglitazone on blood lipid levels and glycemic control in patients with type 2 diabetes mellitus: A retrospective review of randomly selected medical records. Clinical Therapeutics. 24(3). 378–396. 140 indexed citations

19.

Marchetti, Albert, Raf Magar, Helen Lau, et al.. (2001). Pharmacotherapies for attention-deficit/hyperactivity disorder: expected-cost analysis. Clinical Therapeutics. 23(11). 1904–1921. 33 indexed citations

20.

Roffman, Mark, et al.. (1983). Comparative anticholinergic activity of oxaprotiline and amitriptyline. Drug Development Research. 3(6). 561–566. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact